Cargando…
HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration
While beta-amyloid (Aβ), a classic hallmark of Alzheimer’s disease (AD) and dementia, has long been known to be elevated in the human immunodeficiency virus type 1 (HIV-1)-infected brain, why and how Aβ is produced, along with its contribution to HIV-associated neurocognitive disorder (HAND) remains...
Autores principales: | Chai, Qingqing, Jovasevic, Vladimir, Malikov, Viacheslav, Sabo, Yosef, Morham, Scott, Walsh, Derek, Naghavi, Mojgan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688069/ https://www.ncbi.nlm.nih.gov/pubmed/29142315 http://dx.doi.org/10.1038/s41467-017-01795-8 |
Ejemplares similares
-
Author Correction: HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration
por: Chai, Qingqing, et al.
Publicado: (2018) -
Microtubule plus end–associated CLIP-170 initiates HSV-1 retrograde transport in primary human cells
por: Jovasevic, Vladimir, et al.
Publicado: (2015) -
HIV-1 capsids bind and exploit the kinesin-1 adaptor FEZ1 for inward movement to the nucleus
por: Malikov, Viacheslav, et al.
Publicado: (2015) -
Characterisation of FEZ1-mediated inhibition of retroviral replication
por: Brown, Craig, et al.
Publicado: (2009) -
Amyloid precursor protein: more than just neurodegeneration
por: Pimplikar, Sanjay W, et al.
Publicado: (2011)